IDH1 and central nervous system cancer: However, several studies have provided conflicting evidence whereby mutant-IDH reduced HIF-1α expression by the paradoxical 2-HG-mediated activation of PHDs in glioma and haematopoietic cells, and PHD knockdown conferred a proliferative disadvantage in mutant-IDH cells [18,21].